SESSION I SCHEDULE
Wednesday
SESSION I: HEMODIALYSIS ACCESS AT AIMSYMPOSIUM (PART 1)
x
8:00 AM - 8:10 AM Physical Exam: What Radiologists Need To Know
  Presenters(s): Gary A. Gelbfish, MD  
8:10 AM - 8:20 AM Vein Preservation: What Radiologists Need To Know
  Presenters(s): Theodore F. Saad, MD  
8:20 AM - 8:30 AM Ultrasound Exam Of The Failing Access
  Presenters(s): Sanford D. Altman, MD  
8:30 AM - 8:40 AM Arterial Access For Fistula Evaluation And Intervention
  Presenters(s): Jacob Cynamon, MD  
8:40 AM - 8:50 AM Percutaneous Thrombectomy: How I Do It
  Presenters(s): Abigail Falk, MD  
8:50 AM - 9:00 AM Percutaneous Thrombectomy: How I Do It
  Presenters(s): Bart L. Dolmatch, MD  
9:00 AM - 9:10 AM Percutaneous Or Surgical: How I Decide
  Presenters(s): Gary A. Gelbfish, MD  
9:10 AM - 9:20 AM Use Of Stent Grafts In Hemodialysis Access
  Presenters(s): Bart L. Dolmatch, MD  
9:20 AM - 9:30 AM Don’t Stent! I Will Do Surgery
  Presenters(s): Surendra Shenoy, MD, PhD  
9:30 AM - 9:50 AM Panel Discussion
9:50 AM - 10:00 AM Management Of Cephalic Arch Stenoses
  Presenters(s): Theodore F. Saad, MD  
10:00 AM - 10:10 AM Pacemaker-Induced Central Venous Stenosis
  Presenters(s): Stanley G. Cooper, MD  
10:10 AM - 10:20 AM Prevention Of Catheter Exit Site Infection
  Presenters(s): Sanford D. Altman, MD  
10:20 AM - 10:30 AM Surface Coatings For Hemodialysis Catheters
  Presenters(s): Thomas M. Vesely, MD  
10:30 AM - 11:00 AM Break / Visit Exhibits
END OF SESSION I
 
SESSION II SCHEDULE
Wednesday
SESSION II: VASCULAR ACCESS SOCIETY OF THE AMERICAS AT VEITHSYMPOSIUM: HEMODIALYSIS ACCESS (PART 2)
x
PART 2A: FISTULA FIRST: THE GOOD AND THE BAD
11:00 AM - 11:10 AM Fistula First: A Nephrologist’s Perspective
  Presenters(s): Theodore F. Saad, MD  
11:10 AM - 11:20 AM Fistula First: A Surgeon’s Perspective
  Presenters(s): Mitchell L. Henry, MD  
11:20 AM - 11:30 AM Fistula First: A Radiologist’s Perspective
  Presenters(s): Bart L. Dolmatch, MD  
11:30 AM - 11:40 AM The Use Of PTFE Grafts In The Fistula First Era
  Presenters(s): Mitchell L. Henry, MD  
11:40 AM - 11:50 AM Percutaneous Management Of The Non-Maturing Fistula
  Presenters(s): Abigail Falk, MD  
11:50 AM - 12:00 PM Surgical Management Of The Non-Maturing Fistula
  Presenters(s): Surendra Shenoy, MD, PhD  
12:00 PM - 1:00 PM Lunch Break
THIS SESSION RUNS CONCURRENTLY WITH SESSION XII ON ENDOVENOUS MANAGEMENT OF VARICOSE VEINSPART 2B: NEW TECHNOLOGY FOR HEMODIALYSIS ACCESS
1:00 PM - 1:10 PM Current Status Of The Graftcath For Hemodialysis Access
  Presenters(s): Howard E. Katzman, MD  
1:10 PM - 1:20 PM Preliminary Experience With Recombinant Thrombin
  Presenters(s): Fred A. Weaver, MD  
1:20 PM - 1:30 PM Preliminary Experience With The Swirlgraft
  Presenters(s): Marc H. Glickman, MD  
1:30 PM - 1:40 PM Preliminary Experience With The Flixene Graft
  Presenters(s): A. Frederick Schild, MD  
1:40 PM - 1:50 PM Preliminary Experience With The Propaten Graft
  Presenters(s): Ingemar J.A. Davidson, MD, PhD, FACS  
1:50 PM - 2:00 PM Bioprostheses For Hemodialysis Access And Clinical Application Of The ProCol® Graft
  Presenters(s): Howard E. Katzman, MD  
2:00 PM - 2:10 PM Preliminary Experience With The Vascugel Anastomotic Wrap
  Presenters(s): Jeffrey H. Lawson, MD, PhD  
2:10 PM - 2:20 PM Preliminary Experience With A Paclitaxel-Eluding Anastomotic Wrap
  Presenters(s): Ted R. Kohler, MD  
2:20 PM - 2:30 PM Preliminary Experience With The Aventa MicroInfusion Catheter
  Presenters(s): Thomas M. Vesely, MD  
2:30 PM - 2:40 PM New Ultrasound Technology
  Presenters(s): Earl Schuman, MD  
2:40 PM - 3:00 PM Panel Discussion
3:00 PM - 3:20 PM Keynote Address: The Concept of an AV Fistula for Vascular Access
  Presenters(s): Kenneth C. Appell, MD  
3:20 PM - 3:40 PM Refreshment Break / Visit Exhibits
3:40 PM - 3:50 PM The Natural History Of Access In The KDOQI Era
  Presenters(s): Marc H. Glickman, MD  
3:50 PM - 4:00 PM Use Of Ultrasound In Hemodialysis Access
  Presenters(s): Surendra Shenoy, MD, PhD  
4:00 PM - 4:10 PM Hypercoagulability Concerns In Vascular Access Procedures
  Presenters(s): Jeffrey H. Lawson, MD, PhD  
4:10 PM - 4:20 PM Legal Aspects Of Hemodialysis Access
  Presenters(s): Larry A. Scher, MD  
PART 2C: ABSTRACT PRESENTATIONS
Moderator(s): Larry A. Scher, MD  
4:20 PM - 4:30 PM Results Of Aggressive Graft Surveillance And Endovascular Treatment On Secondary Patency Rates Of Vectra Vascular Access Grafts
  Presenters(s): Stavros Kakkos, MD, PhD  
4:30 PM - 4:40 PM Two Stage Basilic And Cephalic Vein Transpositions Can Significantly Improve The Rate Of Fistula Creation
  Presenters(s): Homayoun Hashemi, MD, FACS, RVT  
4:40 PM - 4:50 PM Techniques For Creation Of AV Fistulae In Morbidly Obese Patients
  Presenters(s): Clifford M. Sales, MD, MBA  
END OF SESSION II
 
SESSION IV SCHEDULE
Wednesday
SESSION IV: NEW HORIZONS IN CARDIOVASCULAR SURGERY - PART 2
x
PART 2A: ATRIAL FIBRILLATION
1:30 PM - 1:42 PM A-fib: The Epidemic And Its Costs
  Presenters(s): D. George Wyse, MD  
1:43 PM - 1:55 PM The Maze Procedure: The Surgical Gold Standard
  Presenters(s): A. Marc Gillinov, MD  
1:56 PM - 2:08 PM Success With Catheter-Based Solutions: Is There Still A Role For Surgery?
  Presenters(s): Kenneth Ellenbogen, MD  
2:09 PM - 2:21 PM Surgical Ablation: Choice Of Lesion Set
  Presenters(s): A. Marc Gillinov, MD  
2:22 PM - 2:34 PM New Technologies For Surgical A-fib Ablation
  Presenters(s): Adam E. Saltman, MD, PhD  
2:35 PM - 3:00 PM Panel Discussion
3:00 PM - 3:30 PM Refreshment Break - Visit Exhibits
PART 2B: COMPLEX AORTIC SURGERY
3:30 PM - 3:42 PM Acute Proximal Dissection: Strategies And Results
  Presenters(s): Joseph E. Bavaria, MD  
3:43 PM - 3:55 PM Endovascular Repair Of Proximal Dissection: Is It Feasible?
  Presenters(s): Michael D. Dake, MD  
3:56 PM - 4:08 PM Chronic Dissections With Aneurysms: Results Of Open Surgery
  Presenters(s): Joseph S. Coselli, MD  
4:09 PM - 4:21 PM Endovascular Repair Of Chronic Dissections With Aneurysms: Results And Strategies
  Presenters(s): Eric E. Roselli, MD  
4:22 PM - 4:34 PM Extensive Aneurysms: Single Stage Ascending, Arch, Descending Repair
  Presenters(s): Nicholas T. Kouchoukos, MD  
4:35 PM - 4:47 PM Extensive Aneurysms: The Elephant Trunk Graft For A Staged Approach
  Presenters(s): Lars G. Svensson, MD, PhD  
4:48 PM - 5:15 PM Panel Discussion
END OF SESSION IV
 
SESSION III SCHEDULE
Wednesday
SESSION III: NEW HORIZONS IN CARDIOVASCULAR SURGERY - PART 1
x
8:00 AM - 8:05 AM Introductory Remarks
  Presenters(s): Roy K. Greenberg, MD / Bruce W. Lytle, MD  
PART 1A: IMAGING FOR CARDIAC SURGICAL ISSUES
8:05 AM - 8:17 AM Cardiac CT For CAD: Do We Still Need Angiography
  Presenters(s): Mario J. Garcia, MD  
8:18 AM - 8:30 AM Cardiac CT For Valves: Is It Better Than Echo
  Presenters(s): Michael C. Moon, MD  
8:31 AM - 8:43 AM Intraoperative Imaging Strategies For Cardiovascular Endo Procedures: Fixed Versus Portable Imaging Systems And Room Design
  Presenters(s): Roy K. Greenberg, MD  
8:44 AM - 9:00 AM Panel Discussion
PART 1B: MINIMALLY INVASIVE VALVES I – ROBOTICS AND SURGERY
9:00 AM - 9:10 AM Partial Sternotomy Is The Surgical Gold Standard For Mitral And Aortic Valves
  Presenters(s): Lawrence H. Cohn, MD  
9:11 AM - 9:21 AM Minimally Invasive MVR Through A Right Thoracotomy
  Presenters(s): W. Clark Hargrove III, MD  
9:22 AM - 9:32 AM Evolution Of Robotic Surgery For Cardiac Procedures
  Presenters(s): W. Randolph Chitwood, Jr., MD  
9:33 AM - 9:43 AM Techniques And Midterm Outcomes Of Robotic MVR
  Presenters(s): L. Wiley Nifong, MD  
9:44 AM - 10:00 AM Panel Discussion
10:00 AM - 10:30 AM Break - Visit Exhibits
PART 1C: MINIMALLY INVASIVE VALVES II – ENDOVASCULAR
10:30 AM - 10:40 AM Who Is A Candidate For An Endovascular Aortic Valve?
  Presenters(s): Craig R. Smith, MD  
10:41 AM - 10:51 AM Edwards Transapical And Retrograde Apical Experiences
  Presenters(s): Lars G. Svensson, MD, PhD  
10:52 AM - 11:02 AM Percutaneous Valves: An Interventionalist’s Perspective
  Presenters(s): Carlos E. Ruiz, MD, PhD  
11:03 AM - 11:13 AM Getting Into And Out Of Trouble During Endo AVR
  Presenters(s): Martin B. Leon, MD  
11:14 AM - 11:24 AM Percutaneous Mitral Valve Strategies
  Presenters(s): Samir Kapadia, MD  
11:25 AM - 11:35 AM New Devices: What Else Is Out There?
  Presenters(s): Michael J. Mack, MD  
11:36 AM - 12:00 PM Panel Discussion
PART 1D: DEBATE/DISCUSSION: TRAINING PARADIGMS FOR CARDIOVASCULAR PROGRAMS
12:00 PM - 12:10 PM Future Training In Cardiac Surgery
  Presenters(s): Bruce W. Lytle, MD  
12:11 PM - 12:21 PM Future Training In Vascular Surgery
  Presenters(s): Richard P. Cambria, MD  
12:22 PM - 12:32 PM Future Training In Interventional Cardiology
  Presenters(s): E. Murat Tuzcu, MD  
12:33 PM - 12:43 PM Future Training In Interventional Radiology
  Presenters(s): Barry T. Katzen, MD  
12:44 PM - 1:00 PM Panel Discussion
1:00 PM - 1:30 PM Lunch Break
END OF SESSION III
 
SESSION VI SCHEDULE
Wednesday
SESSION VI: LUNCHEON LECTURES: ENDOVENOUS TREATMENT OF VARICOSE VEINS - PART 2 (10-MINUTE TALKS)
x
THIS SESSION RUNS CONCURRENTLY WITH SESSION X PART 2B: NEW TECHNOLOGY FOR HEMODIALYSIS ACCESS
1:00 PM - 1:10 PM No-Wall-Touch Versus Standard Endovenous Laser Fibers: Are The Postoperative Results Different?
  Presenters(s): Lowell S. Kabnick, MD, FACS, FACPh  
1:10 PM - 1:20 PM ClosureFAST Is Better Than First Generation Radiofrequency Ablation: A Quantum Leap Forward
  Presenters(s): Alan M. Dietzek, MD, FACS, RPVI  
1:20 PM - 1:30 PM Role Of Venous Duplex Ultrasound: Pre-op, Intra-op, And Post-op
  Presenters(s): Neil M. Khilnani, MD  
1:30 PM - 1:40 PM The Role Of Fluoroscopy In The Management Of Varicose Veins
  Presenters(s): Melvin Rosenblatt, MD  
1:40 PM - 1:50 PM The Future Of Venous Imaging: Will It Be Duplex Ultrasound, MRV, Or CTV?
  Presenters(s): Barry Stein, MD, FSIR, FACR  
1:50 PM - 2:00 PM What Is The Best Method For Obliterating Perforators In 2007: SEPS, Surgery, Duplex-Guided Sclerotherapy Or Duplex-Guided Radiofrequency: When Should They Be Used?
  Presenters(s): Peter Gloviczki, MD  
2:00 PM - 2:10 PM Current Information On The Development Of Venous Ulcers
  Presenters(s): Peter J. Pappas, MD  
2:10 PM - 2:20 PM Patterns Of Reflux In The Small Saphenous Vein: Pearls For SSV Ablation
  Presenters(s): Steve Elias, MD  
2:20 PM - 2:30 PM Management Of GSV In The Presence Of Thrombophilia
  Presenters(s): Joseph A. Caprini, MD  
2:30 PM - 2:40 PM Pay For Performance: What's New In CPt 2008? Any Surprises?
  Presenters(s): Richard A. Baum, MD  
2:40 PM - 2:50 PM Recurrent Varicose Veins And Neovascularization
  Presenters(s): Joseph D. Raffetto, MD  
2:50 PM - 3:00 PM Why Is Compression Important?: How Do We Get Patients To Comply?
  Presenters(s): Robert B. McLafferty, MD  
3:00 PM - 3:20 PM Panel Discussion
3:20 PM - 3:30 PM Lessons Learned After 2000 Endovenous Ablations
  Presenters(s): Jose I. Almeida, MD, FACS, RVT  
3:30 PM - 3:40 PM Complications Of Endovenous Therapies And How To Avoid Them
  Presenters(s): Lowell S. Kabnick, MD, FACS, FACPh  
3:40 PM - 3:50 PM Phlebectomy Versus Sclerotherapy For Bulging Varicose Veins?
  Presenters(s): Edward G. Mackay, MD  
3:50 PM - 4:00 PM Light Assisted Stab Phlebectomy: A New Technique For Removal Of Varicose Branch Veins
  Presenters(s): Peter F. Lawrence, MD  
4:00 PM - 4:10 PM The Utility Of The Venous Clinical Severity Score In Limbs Treated By Radiofrequency Saphenous Vein Ablation
  Presenters(s): Michael A. Vasquez, MD  
4:10 PM - 4:20 PM Transdermal Laser Versus Sclerotherapy For Spider Telangiectasias
  Presenters(s): Edward G. Mackay, MD  
4:20 PM - 4:30 PM Certification And Training For The Venous Specialist
  Presenters(s): Mark A. Adelman, MD  
4:30 PM - 4:40 PM Venous Registry: What Is The Prevalence Of CVI?
  Presenters(s): Robert B. McLafferty, MD  
4:40 PM - 4:50 PM The American Venous Forum: What Is It All About?
  Presenters(s): Mark H. Meissner, MD  
4:50 PM - 5:00 PM Phlebology And The Law
  Presenters(s): Lowell S. Kabnick, MD, FACS, FACPh  
5:00 PM - 5:10 PM Transition From Hospital To The Office
  Presenters(s): Mark A. Adelman, MD  
5:10 PM - 5:30 PM Panel Discussion
END OF SESSION VI
 
SESSION V SCHEDULE
Wednesday
SESSION V: ENDOVENOUS TREATMENT OF VARICOSE VEINS - PART 1 (10-MINUTE TALKS)
x
10:30 AM - 10:40 AM Selecting Patients For Saphenous Vein Ablation: Which Vein(s) Need Burning?
  Presenters(s): Robert J. Min, MD, MBA  
10:40 AM - 10:50 AM Understanding CEAP Classification: How Does It Apply To Practice?
  Presenters(s): Joseph D. Raffetto, MD  
10:50 AM - 11:00 AM Varicose Vein Formation: Inherent Wall Defect Or Defective Valves?
  Presenters(s): Joseph D. Raffetto, MD  
11:00 AM - 11:10 AM More Randomized Clinical Trials Are Needed To Determine The Best Treatment Methods For Varicose Veins
  Presenters(s): Mark H. Meissner, MD  
11:10 AM - 11:20 AM We’ve “Got” Plenty Of Data To Show That Endovenous Thermal Ablation Is Superior To Open Surgery
  Presenters(s): Jose I. Almeida, MD, FACS, RVT  
11:20 AM - 11:30 AM Debunking Some Commonly Held Beliefs About Varicose Veins: Some Shocking Myths And Misconceptions About Varicose Veins And Their Treatment
  Presenters(s): Kevin G. Burnand, MBBS, FRCS, MS  
11:30 AM - 11:40 AM Panel Discussion
11:40 AM - 11:50 AM The American College Of Phlebology: What Is It All About?
  Presenters(s): Robert J. Min, MD, MBA  
11:50 AM - 12:00 PM Debate: With Varicose Veins We Really Don’t Need To Obliterate The Great Saphenous Vein!
  Presenters(s): John J. Bergan, MD  
12:00 PM - 12:10 PM Debate: Without Effective Saphenous Vein Ablation Patients Will Develop Varicose Vein Recurrence In Short Order - In The Majority Of Cases
  Presenters(s): Jose I. Almeida, MD, FACS, RVT  
12:10 PM - 12:20 PM International Venous Registry: We Know About The Faux Pas And Don't Need To Relive It
  Presenters(s): Alun H. Davies, MA, DM, FRCS, FHEA  
12:20 PM - 12:30 PM Role Of Foam Sclerotherapy In The Management Of Varicose Veins
  Presenters(s): John J. Bergan, MD  
12:30 PM - 12:40 PM Traditional vs. Endoscopic Saphenous Vein Stripping: A Prospective Randomized Trial
  Presenters(s): Afshin Assadian, MD  
12:40 PM - 1:00 PM Panel Discussion
END OF SESSION V
 
SESSION VII SCHEDULE
Wednesday
SESSION VII: NEW CONCEPTS IN WOUND CARE; WOUND HEALING SOCIETIES; RECALCITRANT LEG ULCERS
Moderators:Dieter O. Mayer, MD
x
12:30 PM - 12:35 PM Opening Remarks
  Presenters(s): Dieter O. Mayer, MD  
PART A: NEW CONCEPTS IN WOUND CARE
12:36 PM - 12:43 PM HEIDI And Targets: Another View Behind Wounds
  Presenters(s): Kevin Conway, MD  
12:43 PM - 12:53 PM Discussion
12:53 PM - 1:00 PM NERDS And STONES
  Presenters(s): Kevin Woo, RN, PhD(C), ACNP  
1:00 PM - 1:10 PM Discussion
1:10 PM - 1:17 PM Science Behind The Vacuum Assisted Closure System
  Presenters(s): Bauer E. Sumpio, MD, PhD  
1:17 PM - 1:27 PM Discussion
1:27 PM - 1:34 PM Extracorporeal Shock Wave Lithotripsy In Wound Healing
  Presenters(s): Alexander Stojadinovic, MD / Wolfgang Schaden, MD  
1:34 PM - 1:44 PM Discussion
1:44 PM - 1:51 PM Psychological Aspects In Wound Healing
  Presenters(s): Loretta Vileikyte, MD, PhD  
1:51 PM - 2:01 PM Discussion
PART B: WOUND HEALING SOCIETIES
Moderator(s): Bauer E. Sumpio, MD, PhD  
2:02 PM - 2:12 PM Introducing The European Wound Management Association
  Presenters(s): Finn Gottrup, MD, DMSci / Peter J. Franks, PhD  
PART C: RECALCITRANT LEG ULCERS
2:13 PM - 2:20 PM Debate: Conservative Treatment Is Always The Best
  Presenters(s): David L. Steed, MD  
2:20 PM - 2:27 PM Debate: Conservative Treatment Is Not Always The Best
  Presenters(s): Dieter O. Mayer, MD  
2:27 PM - 2:37 PM Panel Discussion
2:37 PM - 2:44 PM The Role Of Varicose Vein Surgery In Recalcitrant Venous Leg Ulcers
  Presenters(s): Sebastian E. Debus, MD, PhD  
2:44 PM - 2:51 PM The Role Of Compression In Recalcitrant Venous Leg Ulcers: A New Device For Applying Compression Quantitatively
  Presenters(s): Ross T. Lyon, MD  
2:51 PM - 2:58 PM Autologous Platelet Gel In The Management Of Recalcitrant Ulceration
  Presenters(s): Michael B. Bruce, MBBS, FRACS  
2:58 PM - 3:08 PM Panel Discussion
3:08 PM - 3:15 PM Combination Of Distal Bypass With Free Flaps For Limb Salvage In Ulcerated Legs
  Presenters(s): Werner Lang, MD  
3:15 PM - 3:22 PM Local Flaps For Ulcerated Wounds: A Better Alternative?
  Presenters(s): Peter A. Blume, DPM, FACS  
3:22 PM - 3:32 PM Discussion
END OF SESSION VII
 
SESSION VIII SCHEDULE
Wednesday
SESSION VIII: MRSA IN WOUND CARE; EVIDENCE BASED MEDICINE IN MODERN WOUND CARE; SKIN CARE
Moderators:Gary W. Gibbons, MD
x
PART A: MRSA IN WOUND CARE
3:33 PM - 3:40 PM Debate: The Current Guidelines Dealing With MRSA Are Effective
  Presenters(s): Steven M. Gordon, MD  
3:40 PM - 3:47 PM Debate: The Current Guidelines Dealing With MRSA Are Not Effective
  Presenters(s): Robert Strohal, MD  
3:47 PM - 3:57 PM Panel Discussion
3:57 PM - 4:05 PM Silver Resistant Genes In MRSA: Is This A Concern In Wound Care?
  Presenters(s): Steven Percival, BSc, PhD, FIBMS  
4:05 PM - 4:15 PM Discussion
4:15 PM - 4:22 PM Is There A Need For Antibiotics In The Treatment Of MRSA In Wounds?
  Presenters(s): Thomas Wild, MD  
4:22 PM - 4:32 PM Discussion
PART B: EVIDENCE BASED MEDICINE IN MODERN WOUND CARE
Moderator(s): Bauer E. Sumpio, MD, PhD  
4:33 PM - 4:40 PM Topical Silver For Treating Infected Wounds: A Systematic Review
  Presenters(s): Hester Vermeulen, PhD  
4:40 PM - 4:47 PM Randomized Clinical Trial Of Occlusive Versus Gauze Dressings For Local Wound Care In Surgical Patients
  Presenters(s): Dirk T. Ubbink, MD  
4:47 PM - 4:57 PM Panel Discussion
4:57 PM - 5:04 PM Initial Findings From A Randomized, Controlled, Double-Blind Clinical Investigation Of An Ibuprofen Releasing Dressing On Painful Venous Leg Ulcers
  Presenters(s): Finn Gottrup, MD, DMSci  
5:04 PM - 5:14 PM Discussion
PART C: SKIN CARE
Moderator(s): David L. Steed, MD  
5:15 PM - 5:22 PM Skin Anatomy And The Pathophysiology Of Diabetes And Aging: Therapy To Improve Skin Health
  Presenters(s): Steven R. Kravitz, DPM  
5:22 PM - 5:29 PM Offloading The Diabetic Foot: A Special Form Of Skin Care
  Presenters(s): Andrew J.M. Boulton, MD  
5:29 PM - 5:39 PM Discussion
5:39 PM - 5:46 PM Topical Approaches To Improving Vascular Activity At The Wound Site
  Presenters(s): Darlene E. McCord, PhD  
5:46 PM - 5:53 PM Allergies And Skin Care: Standard For Adequate Skin Care Products
  Presenters(s): Joachim Dissemond, MD  
5:53 PM - 6:03 PM Discussion
6:03 PM - 6:10 PM Closing Remarks
  Presenters(s): Gary W. Gibbons, MD / David L. Steed, MD  
END OF SESSION VIII
 
SESSION IX SCHEDULE
Thursday
SESSION IX: TOPICS OF INTEREST TO INTERVENTIONALISTS, CARDIAC SURGEONS AND VASCULAR SURGEONS (APPROACHES, PERCUTANEOUS VALVES, THORACIC ENDOGRAFTS) (7-MINUTE TALKS)
x
6:40 AM - 6:47 AM Open Aortic Valve Repair: What Are The Challenges For An Endovascular Approach (Video Presentation)
  Presenters(s): Tomislav Mihaljevic, MD  
6:48 AM - 6:55 AM Strategies For Endovascular Aortic Valve Repair: Balloon Expandable And Self-Expanding; Transfemoral And Trans-Apical
  Presenters(s): Martin B. Leon, MD  
6:56 AM - 7:03 AM Strategies For Endovascular Mitral Valve Repair: Leaflet Approximation Versus Annuloplasty
  Presenters(s): Ted Feldman, MD  
7:04 AM - 7:11 AM Complications Of Endovascular Valve Repair: Lessons Learned From Early Experience
  Presenters(s): Michael J. Mack, MD  
7:12 AM - 7:19 AM Anatomic Factors Predictive Of Thoracic Aortic Endograft Collapse As Determined By Ciné MRA: When Will Endografting Be Possible And Not Possible In This High Flow Environment?
  Presenters(s): Bart E. Muhs, MD, PhD / Hence J.M. Verhagen, MD, PhD  
7:20 AM - 7:27 AM Use Of PFO Closure Devices And Endografts For Endovascular Repair Of Ascending Aortic And Arch Aneurysms
  Presenters(s): Edward B. Diethrich, MD  
7:28 AM - 7:35 AM Endograft Repair Of Thoracic Aortic Lesions Close To The Arch Is Still A Challenge
  Presenters(s): Jean-Pierre Becquemin, MD, FRCS  
7:36 AM - 7:43 AM Thoracic Endografting: What Problems Have Been Solved; What Are We Solving; And What Challenges Remain
  Presenters(s): Michael D. Dake, MD  
7:44 AM - 7:51 AM Panel Discussion
END OF SESSION IX
 
SESSION X SCHEDULE
Thursday
SESSION X: MORE TOPICS FOR INTERVENTIONISTS, CARDIAC SURGEONS AND VASCULAR SURGEONS ABOUT THORACIC ENDOGRAFTING (6-MINUTE FAST PACED TALKS)
x
7:51 AM - 7:57 AM Debate: Hybrid Approaches To Thoracic Aortic Aneurysms (TAAs) Involving Arch Vessels: Extra-Anatomic Bypass Is Less Invasive And Best
  Presenters(s): Alan B. Lumsden, MD, FACS  
7:58 AM - 8:04 AM Debate: Direct Approach To TAAs Involving The Arch Vessels By The Elephant Trunk (Hybrid Technique) Is Best And More Durable
  Presenters(s): Lars G. Svensson, MD, PhD  
8:05 AM - 8:11 AM Debate: Treatment Of Thoracoabdominal AAAs Will Be Most Effective If Accomplished With Fenestrated Grafts And Stent-Graft Branches
  Presenters(s): Roy K. Greenberg, MD  
8:12 AM - 8:18 AM Debate: Treatment Of TAAAs Will Be Most Effective If Accomplished With A Branched Main Body And Stent-Graft Extensions
  Presenters(s): Timothy A.M. Chuter, DM  
8:19 AM - 8:25 AM The INSTEAD Trial Update: What Is The Role Of Endografting Versus Medical Management In Uncomplicated Type B Dissections And What Factors Are Predictive Of A Dire Outcome And Justify Early Stent-Grafting?
  Presenters(s): Christoph A. Nienaber, MD, PhD  
8:26 AM - 8:32 AM Results With The Cook Zenith Dissection Device Featuring Covered And Uncovered Stent Portions For Treatment Of Type B Dissections
  Presenters(s): Joseph V. Lombardi, MD  
8:33 AM - 8:39 AM Fenestrated And Branched Stent-Grafts For Diffuse Aortic Arch Lesions: Techniques, Problems And Results
  Presenters(s): Krassi Ivancev, MD, PhD  
8:40 AM - 8:46 AM Long-Term (5-Year) Trial Results Of TAA Repair With The Gore TAG Endograft: Up To 45 mm In Diameter
  Presenters(s): Michel S. Makaroun, MD  
8:47 AM - 8:53 AM Updated Trial Results With The Cook Zenith TX 2 Endograft For Thoracic Aortic Pathology
  Presenters(s): Jon S. Matsumura, MD  
8:54 AM - 9:00 AM Results Of The VALOR Trial For Treatment Of Thoracic Aortic Lesions: Pivotal And High Risk Arms And VALOR II Design
  Presenters(s): Ronald M. Fairman, MD  
9:00 AM - 9:12 AM Panel Discussion
END OF SESSION X
 
SESSION XI SCHEDULE
Thursday
SESSION XI: NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC AORTIC PATHOLOGY: NEWER STENT-GRAFTS, MODIFICATIONS AND COMPLICATIONS (6-MINUTE TALKS)
x
9:12 AM - 9:18 AM Durability Of Branched And Fenestrated Grafts: How Long Can They Last: Are They Ready For Use In Good Risk Patients?
  Presenters(s): John L. Anderson, MD  
9:19 AM - 9:25 AM Advantages And Current Limitations Of Endograft Treatment Of Acute Traumatic Disruption Of The Aorta: Needs For The Future And Challenges For Current Thoracic Graft Designs
  Presenters(s): Mark A. Farber, MD  
9:26 AM - 9:32 AM Update On The Bolton Relay Graft For Thoracic Aortic Pathology: What Are Its Advantages And Limitations?
  Presenters(s): Vicente Riambau, MD, PhD  
9:33 AM - 9:39 AM Results Of Gore TAG Device For Complex Thoracic Pathology: Ruptured TAAs And Complicated Type B Dissections: A Multicenter Study
  Presenters(s): Richard P. Cambria, MD / Christopher J. Kwolek, MD  
9:40 AM - 9:46 AM Are Current Thoracic Aortic Grafts The Answer: Do We Need A Better Graft And Will It Be Available? The VI Thoracic Graft
  Presenters(s): Juan C. Parodi, MD  
9:47 AM - 9:53 AM Ten-Year Experience With TEVAR: It Is Not All Perfect
  Presenters(s): Gioacchino Coppi, MD  
9:54 AM - 10:00 AM Treatment Of Coarctation Of The Aorta With Covered Balloon Expandable Stents
  Presenters(s): Elchanan Bruckheimer, MBBS  
10:00 AM - 10:07 AM Techniques For Dealing With Short Bad Necks In Urgent Pararenal Aneurysms: Surgeon Modified Fenestrated Grafts And Chimney Stent-Grafts: Techniques Of Preparation And Results
  Presenters(s): Krassi Ivancev, MD, PhD / Martin Malina, MD, PhD / Timothy A. Resch, MD, PhD  
10:08 AM - 10:18 AM Panel Discussion
END OF SESSION XI
 
SESSION XII SCHEDULE
Thursday
SESSION XII: NEW DEVELOPMENTS IN SFA AND CRURAL ARTERY TREATMENTS: THE STATE-OF-THE-ART AND NEW ADJUNCTS (6-MINUTE TALKS)
x
10:18 AM - 10:24 AM Biomechanical Bases For Treatment Of SFA Disease: Factors Involving Stents And The Artery: Can They Be Resolved And How To Design The Perfect Stent For The SFA
  Presenters(s): Daniel Y. Sze, MD, PhD  
10:25 AM - 10:31 AM Debate: Late Results With The Silverhawk Device: Rotational Atherectomy For Infrainguinal Arteriosclerosis Is A Good Thing
  Presenters(s): Venkatesh G. Ramaiah, MD  
10:32 AM - 10:38 AM Debate: Durability Of Treatment With The Silverhawk Atherectomy Device: Why It Has Limited Value
  Presenters(s): Timur P. Sarac, MD  
10:39 AM - 10:45 AM Present And Future Of Endovascular SFA Treatment: Stents, Stent-Grafts, Drug Coated Balloons And Drug Coated Stents: What’s On The Horizon?
  Presenters(s): Marc Bosiers, MD  
10:46 AM - 10:52 AM New Concepts In Atherectomy Devices And Stents And Their Role In Tibial Artery Disease: Will Drug Eluting Stents Help?
  Presenters(s): Dierk Scheinert, MD  
10:53 AM - 10:59 AM How Good Are Present Stents In The SFA And Popliteal Arteries: Will Bioabsorbable Stents Or New Lasers (Turbobooster) Help?
  Presenters(s): Giancarlo Biamino, MD, PhD  
11:00 AM - 11:06 AM Limits Of Endovascular Treatment Of Femoropopliteal Occlusive Disease: Gender, Diabetes, Calcification And Aneurysmal Disease Make A Difference: What Is The Need For Embolic Protection?
  Presenters(s): Klaus D. Hagspiel, MD  
11:07 AM - 11:13 AM Late Results (3-5 Years) With Zilver Plain Nitinol Stents For TASC C & D SFA Lesions
  Presenters(s): Marcelo Ferreira, MD  
11:14 AM - 11:20 AM Will Drug Eluting Stents Do Better In The SFA: Results With The Cook Zilver PTX Drug Coated Stent Without A Polymer
  Presenters(s): Michael D. Dake, MD  
11:21 AM - 11:27 AM Results With The Edwards Life Stent For Femoropopliteal Occlusive Disease: Does The Stent Make A Difference In This Difficult Location: The RESILIENT Trial Results
  Presenters(s): Barry T. Katzen, MD  
11:28 AM - 11:35 AM Panel Discussion
END OF SESSION XII
 
SESSION XIII SCHEDULE
Thursday
SESSION XIII: NEW DEVELOPMENTS IN TEVAR AND EVAR (5-MINUTE FAST PACED TALKS)
x
11:35 AM - 11:40 AM Debate: Fenestrated Grafts Are Necessary In A Substantial Percentage Of AAA Patients
  Presenters(s): Eric L.G. Verhoeven, MD, PhD  
11:41 AM - 11:46 AM Debate: Fenestrated Grafts Are Used Too Often And Are Only Necessary In A Small Percentage Of AAA Patients
  Presenters(s): Jacob Buth, MD  
11:47 AM - 11:52 AM Branched Grafts To Preserve Hypogastric Arteries
  Presenters(s): John L. Anderson, MD  
11:53 AM - 11:58 AM Safety Of Bilateral Hypogastric Artery Interruption When Necessary
  Presenters(s): Manish Mehta, MD, MPH / Frank J. Veith, MD  
11:59 AM - 12:04 PM Debate: The Role Of Open Surgery For TAAs And TAAAs Will Be Substantial In The Endovascular Era: Open Surgery Is Still The Gold Standard
  Presenters(s): Hazim J. Safi, MD  
12:05 PM - 12:10 PM Debate: The Role Of Open Surgery In The Endovascular Era Will Be Minimal
  Presenters(s): Timothy A.M. Chuter, DM  
12:11 PM - 12:16 PM Who Should Be Treating Thoracic And Thoracoabdominal Aneurysms For The Patient’s Sake: Who, When, How And Where?
  Presenters(s): Michael J. Jacobs, MD  
12:17 PM - 12:22 PM A New Endograft For Total Aortic Arch Replacement
  Presenters(s): Syde A. Taheri, MD  
12:23 PM - 12:28 PM Influence Of Stent Type On Hemodynamic Changes (Depression) After CAS
  Presenters(s): Barry T. Katzen, MD  
12:29 PM - 12:39 PM Panel Discussion
12:40 PM - 1:30 PM Luncheon Break
END OF SESSION XIII
 
SESSION XIV SCHEDULE
Thursday
SESSION XIV: CRITICAL EVALUATION OF CAROTID ARTERY STENTING (CAS) (6-MINUTE TALKS)
x
1:30 PM - 1:36 PM CAS vs. CEA vs. Medical Treatment: How To Choose Without Bias
  Presenters(s): Michael R. Jaff, DO  
1:37 PM - 1:43 PM How To Pick By Duplex Ultrasonography Asymptomatic Patients Who Will Develop Symptoms And Who Need Treatment
  Presenters(s): Jose Fernandes e Fernandes, MD, PhD, FRCS (Eng), FACS  
1:44 PM - 1:50 PM Carotid Plaque Characteristics And Their Therapeutic And Prognostic Implications
  Presenters(s): Giorgio M. Biasi, MD  
1:51 PM - 1:57 PM CAS Is Emerging As Best And Safest When Carotid Intervention May Not Be Needed At All: Is CEA Now Best After All And Will This Change With Better Devices?
  Presenters(s): Frank J. Criado, MD, FACS, FSVM  
1:58 PM - 2:04 PM Are Statins Indicated Before CEA: How Long Before Should They Be Started?
  Presenters(s): Bruce A. Perler, MD, MBA  
2:05 PM - 2:11 PM Statins Prevent Strokes: The SPARCLE Trial: Does It Render NASCET, ECST, ACAS, ACST Obsolete And Mandate New Trials Of Best Medical Treatment Versus CEA And CAS?
  Presenters(s): Henrik Sillesen, MD, DMSc  
2:12 PM - 2:18 PM What Lesion Characteristics Are Associated With Increased Risk Of Stroke With CAS: Long Lesions Are Dangerous
  Presenters(s): Michel S. Makaroun, MD / Mark H. Wholey, MD  
2:19 PM - 2:25 PM CAS Can Be Done Without Cerebral Embolic Protection: How Can This Be Done Safely?
  Presenters(s): Franco Perona, MD  
2:26 PM - 2:32 PM Strategies For Avoiding Embolic And Non-Embolic Stroke With CAS: How To Choose An Embolic Protection Device
  Presenters(s): Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD  
2:33 PM - 2:40 PM Panel Discussion
Moderator(s): Jean-Pierre Becquemin, MD, FRCS / Keith D. Calligaro, MD  
2:40 PM - 2:46 PM Debate: CAS Is Currently Being Underutilized Viz A Viz Medical Treatment And CEA: Reflections On CAS By A Master Who Has Done More Than 1,000
  Presenters(s): Mark H. Wholey, MD  
2:47 PM - 2:53 PM Debate: CAS Is Currently Being Overutilized Viz A Viz Medical Treatment And CEA
  Presenters(s): Peter R.F. Bell, MD, FRCS, DSC, KBE  
2:54 PM - 3:00 PM Update On The German SPACE Trial: One Year Outcome Results With Subgroup Analysis: CEA vs. CAS In Symptomatic Patients
  Presenters(s): Hans-Henning Eckstein, MD, PhD  
3:01 PM - 3:07 PM The EVA-3S Trial Was Flawed Because The Interventionists Were Inexperienced And Not Representative Of The Best: One Participant’s View
  Presenters(s): Max Amor, MD  
3:08 PM - 3:14 PM The EVA-3S Trial Was Not Flawed Because The Interventionists Were State-Of-The-Art And Got Better Outcomes In Symptomatic Patients Than In The CAPTURE Trial: What Conclusion Should We Reach: The View Of Other Participants
  Presenters(s): Jean Michel Bartoli, MD / Philippe Piquet, MD  
3:15 PM - 3:21 PM Most Strokes Following CAS Occur After Embolic Protection Is Over: EVA-3S Was Not Flawed: Another Participant’s View
  Presenters(s): Emmanuel M. Houdart, MD  
3:22 PM - 3:28 PM Do We Need A Trial Comparing Current Best Medical Therapy Against CEA And CAS: What Is The Status Of The TACIT Trial: Will It Ever Happen?
  Presenters(s): John H. Rundback, MD, FSIR, FAHA  
3:29 PM - 3:38 PM Panel Discussion
END OF SESSION XIV
 
SESSION XV SCHEDULE
Thursday
SESSION XV: NEW DEVELOPMENTS OF INTEREST TO INTERVENTIONISTS AND VASCULAR SURGEONS: STENT-GRAFTS IN THE SFA AND OTHER NEW METHODS (6-MINUTE TALKS)
x
3:38 PM - 3:44 PM Is There Still A Role For Open Surgery For Fem-Pop-Tibial Disease?
  Presenters(s): Enrico Ascher, MD  
3:45 PM - 3:51 PM 10-Year Experience With Viabahn Covered Stents For Long Femoropopliteal Occlusions: Technique, Results And Limitations
  Presenters(s): Jacques Bleyn, MD  
3:52 PM - 3:58 PM Use Of The Viabahn Stent-Graft For Chronic Total SFA Occlusions: A Note Of Caution
  Presenters(s): W. Anthony Lee, MD  
3:59 PM - 4:05 PM Role Of Stent-Grafts And Stents For SFA Occlusive Disease: Which Is Better And Under What Circumstances: Results Of The VIBRANT Trial Comparing Viabahn With Bare Metal Nitinol Stents
  Presenters(s): Mark W. Mewissen, MD  
4:06 PM - 4:12 PM The SAFARI Technique For Subintimal Angioplasty Of Tibial Vessels Employing A Distal Puncture Site
  Presenters(s): Klaus D. Hagspiel, MD  
4:13 PM - 4:19 PM Late Results After Viabahn Repair Of Popliteal Aneurysms
  Presenters(s): Jose Luis C. Nascimento Silva, MD  
4:20 PM - 4:26 PM 9-Month Clinical Results With A Biologically Covered Stent-Graft For Treating SFA Occlusions
  Presenters(s): Albrecht H. Krämer, MD / Timur P. Sarac, MD / Pierre Galvagni Silveira, MD, PhD  
4:27 PM - 4:35 PM Panel Discussion
END OF SESSION XV
 
SESSION XVI SCHEDULE
Thursday
SESSION XVI: PREVENTION AND MANAGEMENT OF COMPLICATIONS (7-MINUTE TALKS)
x
4:35 PM - 4:42 PM Complications Of Closure Devices: Tips And Tricks To Avoid Them And How To Manage Them
  Presenters(s): Jos C. van den Berg, MD, PhD  
4:43 PM - 4:50 PM Incidence And Importance Of Hypotension And Bradycardia With CAS: How To Predict And Manage Them
  Presenters(s): Peter H. Lin, MD  
4:51 PM - 4:58 PM For CAS Which Stent, Which Protection System Should We Use And Why: Which Lesion Should We Not Treat?
  Presenters(s): Marc Bosiers, MD  
4:59 PM - 5:06 PM How To Make CAS Safer
  Presenters(s): Emmanuel M. Houdart, MD  
5:07 PM - 5:14 PM Do Statins Reduce Myocardial Ischemia And Infarctions During Vascular Procedures: Why Must All Patients Be On Them Beforehand?
  Presenters(s): Don Poldermans, MD  
5:15 PM - 5:22 PM Technical And Device Adjustments For Endograft Treatment Of True And False Lumen Problems In Complex Aortic Dissections: How To Prevent Strokes
  Presenters(s): Geoffrey H. White, MD  
5:23 PM - 5:30 PM Is Embolic Protection Necessary For Renal Stenting: How Should It Be Done And When Can’t It Be Done?
  Presenters(s): Jon G. Moss, MD  
5:31 PM - 5:40 PM Panel Discussion
END OF SESSION XVI
 
SESSION XVII SCHEDULE
Thursday
SESSION XVII: UPDATES AND NEW CONCEPTS IN VASCULAR DISEASE AND ITS TREATMENT (7-MINUTE TALKS)
Moderators:Juan C. Parodi, MD
x
5:40 PM - 5:47 PM The Truth About The Thrombosis Problem With Drug Eluting Stents In The Coronary Circulation: It’s Not As Bad As We Have Been Led To Believe
  Presenters(s): Gregg W. Stone, MD  
5:47 PM - 5:54 PM The Truth About The Drawbacks Of Drug Eluting Stents: It’s Worse Than We Have Been Led To Believe
  Presenters(s): Renu Virmani, MD  
5:55 PM - 6:02 PM Where Are We Going With Drug Eluting Stents: How Much Better Will They Get: Will Coronary Stenting Increase Or Decrease?
  Presenters(s): Martin B. Leon, MD  
6:03 PM - 6:10 PM New Horizons In Imaging And Remote Guidance Of Catheter And Guidewire Tips And Stiffness: How Will These Make A Difference?
  Presenters(s): Alan B. Lumsden, MD, FACS / William Hendren, MD  
6:11 PM - 6:18 PM Experience With Stent Grafts (Viabahn) In The Treatment Of Superficial Femoral Artery Occlusions And Popliteal Aneurysms
  Presenters(s): Giovanni P. Deriu, MD  
6:19 PM - 6:26 PM Really Long-Term Follow-up (10 Years) Of Iliac And Aortic Stents And Kissing Stents
  Presenters(s): Götz M. Richter, MD, PhD  
6:27 PM - 6:34 PM CO2 As A Contrast Agent For EVAR: Technique, Advantages And Limitations
  Presenters(s): Fred A. Weaver, MD  
6:35 PM - 6:42 PM New Developments In Oral Anticoagulants: Will Heparin And Coumadin Be Replaced And Why?
  Presenters(s): William M. Stone, MD / Samuel R. Money, MD, MBA  
6:43 PM - 6:53 PM Panel Discussion
END OF SESSION XVII
 
SESSION XVIII SCHEDULE
Thursday
SESSION XVIII: ISVS AWARD PAPERS (8-MINUTE TALKS)
x
6:53 PM - 7:01 PM A Prospective Clinical, Economic And Quality Of Life Analysis Of Open Repair (OR), Endovascular Repair (EVAR) And Best Medical Treatment (BMT) In High-Risk Patients With Abdominal Aortic Aneurysms (AAA) Suitable For EVAR: The Irish Patient Trial
  Presenters(s): Sherif Sultan, MD, FRCS, EBQS-VASC  
7:02 PM - 7:10 PM Perioperative Microemboli And Platelet Aggregation In Patients Undergoing Carotid Endarterectomy
  Presenters(s): Thijs J.M. Vogten, MD, PhD  
7:11 PM - 7:19 PM Reliability Of Aortic Diameters In Patients With Hypovolemic Shock: A Challenge For Endograft Sizing
  Presenters(s): Joffrey van Prehn, MD  
7:20 PM - 7:28 PM The Effect Of Blood Pressure On Aneurysm Size In The Presence Of A Type II Endoleak
  Presenters(s): Jade S. Hiramoto, MD  
7:29 PM - 7:35 PM Panel Discussion
END OF SESSION XVIII
 
SESSION XIX SCHEDULE
Friday
SESSION XIX: FOCUS ON NEW OR IMPROVED TECHNOLOGY AND RESULTS THEREFROM (7-MINUTE TALKS)
x
6:40 AM - 6:47 AM How To Perform Cryotherapy, Atherectomy And Laser Treatment For Lower Extremity Occlusive Disease: How Do We Know They Are Worthwhile And Worth The Cost?
  Presenters(s): Kim J. Hodgson, MD  
6:48 AM - 6:55 AM Results With Cryoplasty To Treat Below-Knee Lesions: Is It Better Than Other Techniques?
  Presenters(s): Thomas O. McNamara, MD  
6:56 AM - 7:03 AM What’s Cool About Cryoplasty: 2 ½ -Year Results Based On An Analysis Of Treated Lesions
  Presenters(s): Russell H. Samson, MD, RVT, FACS  
7:04 AM - 7:11 AM What Is The Evidence For The Efficacy Of Cryoplasty?
  Presenters(s): David O. Kessel, MD  
7:12 AM - 7:19 AM Clopidogrel Resistance in CAS: How to Diagnose It and Manage It
  Presenters(s): Zvonimir Krajcer, MD, FACC  
7:20 AM - 7:28 AM Panel Discussion
7:28 AM - 7:35 AM General Remarks About The Meeting
  Presenters(s): Frank J. Veith, MD  
END OF SESSION XIX
 
SESSION XX SCHEDULE
Friday
SESSION XX: PROGRESS IN THE TREATMENT OF THORACIC AND THORACOABDOMINAL AORTIC ANEURYSMS (7-MINUTE TALKS)
x
7:35 AM - 7:42 AM Tips And Tricks For Performing Aortic Arch Debranching Safely
  Presenters(s): Blair A. Keagy, MD  
7:43 AM - 7:50 AM Complications Of Arch And Visceral Debranching: It’s Not Easy And Has Morbidity And Mortality: When Is It Better To Use Endovascular Graft Revascularization Of Branches With Open Repair (The Viabahn Open Repair Technique)?
  Presenters(s): Mario Lachat, MD / Dieter O. Mayer, MD  
7:51 AM - 7:58 AM Laparoscopic Debranching To Facilitate EVAR: Is It Better Than Open Debranching And Branched Endografts?
  Presenters(s): Ralf R. Kolvenbach, MD  
7:59 AM - 8:06 AM Can The Celiac Axis Origin Be Covered Safely By Thoracic Endografts: Indications And Precautions
  Presenters(s): William D. Jordan, Jr., MD  
8:07 AM - 8:14 AM EVAR And TEVAR For Mycotic Aneurysms And Aortovisceral Fistulas: How To Make Them Work
  Presenters(s): George H. Meier III, MD  
8:15 AM - 8:22 AM Computer Automated Planning For Branched And Fenestrated Endografts
  Presenters(s): Roy K. Greenberg, MD  
8:23 AM - 8:30 AM Are There Anatomical Limitations To Fenestrated And Branched Endografts For Pararenal And Thoracoabdominal Aneurysms?
  Presenters(s): Eric L.G. Verhoeven, MD, PhD  
8:31 AM - 8:38 AM What’s New In In Situ Fenestration With Thoracic Stent Grafts?
  Presenters(s): Ramesh K. Tripathi, MD, FRCS, FRACS  
8:39 AM - 8:46 AM What Is The Explanation For Performance Differences With The Gore TAG Endograft In The Pivotal Trial And In Subsequent Usage?
  Presenters(s): Jon S. Matsumura, MD  
8:47 AM - 8:54 AM Use Of CardioMems Pressure Sensor With TEVAR: Can It Improve Outcomes?
  Presenters(s): Karthikeshwar Kasirajan, MD  
8:55 AM - 9:05 AM Panel Discussion
END OF SESSION XX
 
SESSION XXI SCHEDULE
Friday
SESSION XXI: NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY ARTERIAL DISEASE (5-MINUTE FAST PACED TALKS)
x
9:05 AM - 9:10 AM Supervised Exercise For Intermittent Claudication: A Forgotten Treatment Method
  Presenters(s): Alun H. Davies, MA, DM, FRCS, FHEA  
9:11 AM - 9:16 AM Do SFA Stents And Other Treatment Method Trials Require A “Best Medical Treatment Control Cohort”?
  Presenters(s): Samuel E. Wilson, MD  
9:17 AM - 9:22 AM What Is The Level I Evidence Showing That Stenting Is Better Than Plain Old Balloon Angioplasty For Occlusive Lesions In The SFA?
  Presenters(s): Johannes Lammer, MD  
9:23 AM - 9:28 AM Debunking The Myth That Failed SFA Interventions Or Bypasses Convert A Patient With Claudication To Critical Ischemia
  Presenters(s): Christopher L. Wixon, MD  
9:29 AM - 9:34 AM Axillopopliteal Bypass: Does It Have A Role In Today’s Vascular Treatment: Indications, Results And Techniques
  Presenters(s): Frans L. Moll, MD, PhD  
9:35 AM - 9:40 AM Debate: Worldwide Clinical Performance Of Gore Propaten Heparin Bonded PTFE Grafts To Below-Knee Arteries: Will They Be Better Than Saphenous Vein Or Distaflo™ Grafts?
  Presenters(s): Richard F. Neville, MD  
9:41 AM - 9:46 AM Debate: Distaflo™ Grafts: Are They Better Than Vein Or Propaten Grafts?
  Presenters(s): Peter L. Harris, MD, FRCS  
9:47 AM - 9:52 AM Long-Term Results Of Subintimal Recanalization Below The Inguinal Ligament
  Presenters(s): Krassi Ivancev, MD, PhD  
9:53 AM - 10:00 AM Panel Discussion
Moderator(s): Robert B. Rutherford, MD / R. Clement Darling III, MD  
10:00 AM - 10:05 AM Comparison Of Surgical And Endovascular Revision Of Failing Infrainguinal Bypass Grafts: When Is Endovascular Equivalent And When Inferior?
  Presenters(s): Michael S. Conte, MD  
10:06 AM - 10:11 AM Effect Of Lesion Characteristics, Diabetes And Runoff On Outcome Of Lower Extremity Angioplasty And Stenting: Is Bypass Ever A Preferred Option?
  Presenters(s): Peter L. Faries, MD, FACS  
10:12 AM - 10:17 AM Debate: Duplex Surveillance Is Worthwhile After Endovasclar Procedures On Infrainguinal Arteries: Is It Better Than Warfarin?
  Presenters(s): Dennis F. Bandyk, MD  
10:18 AM - 10:23 AM Debate: Duplex Surveillance Is Not Worthwhile After Endovascular Procedures On Infrainguinal Arteries
  Presenters(s): Joseph L. Mills, MD  
10:24 AM - 10:29 AM A New Dorsolateral Approach To The Perineal Artery For Limb Salvage Bypasses: Techniques And Advantages
  Presenters(s): Sebastian E. Debus, MD, PhD  
10:30 AM - 10:35 AM Angiogenic Gene Therapy In Chronic Limb Ischemia: Is There Any Hope That It Will Work?
  Presenters(s): Richard J. Powell, MD  
10:36 AM - 10:41 AM Popliteal Volume Flow Measurements With Duplex Is A Reliable Predictor Of Early And Midterm Patency After PTA And Subintimal PTA: It Should Be A Guide For Stent Placement
  Presenters(s): Anil P. Hingorani, MD  
10:42 AM - 10:47 AM What Factors Make Popliteal Aneurysms Appropriate For Endograft Repair And Which Ones Mandate Open Repair?
  Presenters(s): Martin R. Back, MD  
10:48 AM - 10:56 AM Panel Discussion
END OF SESSION XXI
 
SESSION XXII SCHEDULE
Friday
SESSION XXII: ADVANCES IN MEDICAL TREATMENTS AND TREATMENT OF MEDICAL PROBLEMS IN VASCULAR PATIENTS (7-MINUTE TALKS)
x
10:56 AM - 11:03 AM What Vascular Surgeons Need To Know About Best Medical Treatment In 2007?
  Presenters(s): Russell H. Samson, MD, RVT, FACS  
11:04 AM - 11:11 AM What Is Optimal Antiplatelet Management In 2007?
  Presenters(s): Anthony J. Comerota, MD, FACS, FACC  
11:12 AM - 11:19 AM So You Think Aspirin Was Forever: A New Look At Antiplatelet And Antiinflammatory Activity In Vascular Disease Patients
  Presenters(s): A. Ross Naylor, MD, FRCS  
11:20 AM - 11:27 AM Update On The Rheos System For Treating Drug Resistant Hypertension With An Implantable Carotid Sinus Stimulator: Will It Be Important To Vascular Surgeons?
  Presenters(s): Jürg Schmidli, MD  
11:28 AM - 11:35 AM Where Have All The Atherosclerotic Plaques Gone And What Effect Will It Have On Vascular Surgeons?
  Presenters(s): Allan D. Callow, MD, PhD  
11:36 AM - 11:43 AM New Strategies For Preventing Restenoses After Non-Cardiac Interventions: Drug-Eluting Stents And Balloons, Systemic Drugs And Nano Particles
  Presenters(s): Lindsay Machan, MD  
11:44 AM - 11:51 AM Will There Ever Be Medical Treatment To Prevent AAA Growth
  Presenters(s): Robert W. Thompson, MD  
11:52 AM - 11:58 AM Aggressive Management Of Massive PE By Catheter Manipulation Without Thrombolytics, Pulmonary Embolectomy Or Clot Extraction
  Presenters(s): Jacob Cynamon, MD  
12:05 PM - 1:00 PM Lunch Break
11:59 PM - 12:05 PM Panel Discussion
END OF SESSION XXII
 
SESSION XXIII SCHEDULE
Friday
SESSION XXIII: MORE ABOUT ANEURYSMS AND THEIR TREATMENT (6-MINUTE TALKS)
x
1:00 PM - 1:06 PM Direct Sheath Placement Into The Aorta Or Common Iliac Artery To Facilitate Access For TEVAR Or EVAR: When Is It Better Than A Conduit?
  Presenters(s): Jeffrey P. Carpenter, MD  
1:07 PM - 1:13 PM Debate: Small AAAs Do Not Become Less Suitable For EVAR If They Are Observed For Long Periods: We Don’t Need A Small AAA Trial
  Presenters(s): Carlos H. Timaran, MD  
1:14 PM - 1:20 PM Debate: Small AAAs Do Become Less Suitable For EVAR If They Are Observed: We Do Need A Small AAA Trial: When Will The PIVOTAL Trial Results Be Known?
  Presenters(s): Daniel G. Clair, MD / Kenneth Ouriel, MD, FACS, FACC  
1:21 PM - 1:27 PM With Small AAAs (<5.0 cm), What Are The Predictive Factors For Major Future Growth?
  Presenters(s): Frans L. Moll, MD, PhD  
1:28 PM - 1:34 PM The EUROSTAR Registry: What Has It Accomplished In Its 10-Year Lifespan?
  Presenters(s): Peter L. Harris, MD, FRCS  
1:35 PM - 1:41 PM Comparative Results Of The Zenith And Talent Grafts In The EVAR Trials: Was There A Performance Difference?
  Presenters(s): Roger M. Greenhalgh, MD  
1:42 PM - 1:48 PM Which Is The Best Endograft For AAAs: When Is One Device Better?
  Presenters(s): Clifford J. Buckley, MD  
1:49 PM - 1:55 PM Comparison Of Device Related Complications With Different Grafts In The EUROSTAR Registry
  Presenters(s): Jacob Buth, MD  
1:56 PM - 2:02 PM The End Of Endotension After EVAR: Visualizing Microendoleaks With The New Blood Pool Agent VASOVIST (99): Are These Microendoleaks The Whole Story?
  Presenters(s): Hence J.M. Verhagen, MD, PhD  
2:02 PM - 2:10 PM Panel Discussion
END OF SESSION XXIII
 
SESSION XXIV SCHEDULE
Friday
SESSION XXIV: PROGRESS IN VASCULAR IMAGING (7-MINUTE TALKS)
x
2:10 PM - 2:17 PM Debate: With Asymptomatic Patients Who Have Arteriosclerotic Risk Factors, The Emphasis Should Be Placed On Carotid Screening Not Medical Treatment
  Presenters(s): Glenn Jacobowitz, MD  
2:18 PM - 2:25 PM Debate: With Asymptomatic Patients Who Have Arteriosclerotic Risk Factors, The Emphasis Should Be Placed On Good Medical Treatment (Statins, Beta Blockers, Etc.) Not On Carotid Screening
  Presenters(s): Geoffrey L. Gilling-Smith, MS, FRCS  
2:26 PM - 2:33 PM 3D CTA Imaging Of Carotid Lesions Casts A New Light On Degree Of Stenosis
  Presenters(s): Thomas S. Maldonado, MD  
2:34 PM - 2:41 PM MRA vs. CTA: Which Is Best For Vascular Imaging In What Locations: Can Gadolinium Be Toxic In Some Settings And What Is Nephrogenic Systemic Fibrosis?
  Presenters(s): Geoffrey D. Rubin, MD  
2:42 PM - 2:49 PM New Techniques In Cross-Sectional Imaging: Why Vascular Surgeons Must Master 3D Workstation Skills: What Can Coronary CTA With 64 Slice Scanners Do And Not Do?
  Presenters(s): Geoffrey D. Rubin, MD  
2:50 PM - 2:57 PM Importance Of Dynamic Imaging Modalities With CT And MR On Aneurysmal Disease And Its Treatment With EVAR
  Presenters(s): Hence J.M. Verhagen, MD, PhD  
2:58 PM - 3:05 PM Improvements In IVUS: Why Every Interventionist Must Have It And Use It
  Presenters(s): Rodney A. White, MD  
3:06 PM - 3:15 PM Panel Discussion
END OF SESSION XXIV
 
SESSION XXV SCHEDULE
Friday
SESSION XXV: NEW DEVELOPMENTS IN DIALYSIS ACCESS AND VASCULAR DISEASE AND ITS TREATMENT (7-MINUTE TALKS)
x
3:15 PM - 3:22 PM Does DOQI Have It Right?
  Presenters(s): Marc H. Glickman, MD  
3:23 PM - 3:30 PM Duplex Diagnosis And Treatment Of Failing AV Access Fistulas And Grafts: A Better More Financially Effective Way
  Presenters(s): Enrico Ascher, MD  
3:31 PM - 3:38 PM Update On The Importance Of The VAC Device To Vascular Surgeons
  Presenters(s): Bauer E. Sumpio, MD, PhD  
3:39 PM - 3:46 PM Intima To Media Thickness As A Marker Of Arteriosclerotic Risk
  Presenters(s): Richard Hayes, MD, FACC  
3:47 PM - 3:52 PM Panel Discussion
END OF SESSION XXV
 
SESSION XXVI SCHEDULE
Friday
SESSION XXVI: PROGRESS IN THE TREATMENT OF VENOUS DISEASE (6-MINUTE TALKS)
x
3:52 PM - 3:58 PM How Long After An Episode Of DVT Should Anticoagulation Be Continued?
  Presenters(s): Anthony J. Comerota, MD, FACS, FACC  
3:59 PM - 4:05 PM Does Endovascular Ablation For Varicose Veins Cut The Mustard: Results Of A Prospective Randomized Trial From New Zealand
  Presenters(s): Ramesh K. Tripathi, MD, FRCS, FRACS  
4:06 PM - 4:12 PM Minimal Doses Of Thrombolytic Agent For Treating DVT And Preventing Chronic Venous Insufficiency: Does Intraprocedural Ultrasound Help?
  Presenters(s): Cynthia K. Shortell, MD  
4:13 PM - 4:19 PM Results Of Endovenous Treatment In 1,500 Patients With Ileocaval Venous Obstruction: What Vascular Surgeons Need To Know
  Presenters(s): Seshadri Raju, MD  
4:20 PM - 4:26 PM Determination Of Resolution Of Upper Extremity Venous Thrombosis: Should Invasive Treatment Be Selective?
  Presenters(s): Gregory L. Moneta, MD  
4:27 PM - 4:33 PM Is First Rib Resection Worthwhile For Chronically Occluded Subclavian Veins?
  Presenters(s): Julie Ann Freischlag, MD  
4:34 PM - 4:40 PM Long-Term Results With Aggressive And Conservative Treatment For Effort Thrombosis Of The Axillary-Subclavian Veins: Is Aggressive Treatment Really Indicated And What Should It Be?
  Presenters(s): Karl A. Illig, MD  
4:41 PM - 4:47 PM Comprehensive Surgical Treatment For Subclavian Vein Effort Thrombosis: Who, What, When, Where And Why?
  Presenters(s): Robert W. Thompson, MD  
4:48 PM - 4:54 PM New Techniques And Methods For Treating Ileofemoral DVT
  Presenters(s): Michael B. Silva, Jr., MD  
4:55 PM - 5:01 PM Pharmaco-Mechanical Treatment Of DVT: Emerging Device And Clinical Data Using Isolated Thrombolysis
  Presenters(s): Anthony J. Comerota, MD, FACS, FACC  
5:02 PM - 5:10 PM Panel Discussion
Moderator(s): Bo G. Eklof, MD, PhD / Michael C. Dalsing, MD  
5:10 PM - 5:16 PM Modern Detection And Management Of DVT: Clinical Parameters, D-dimers And Duplex In The Era Of Cost Containment
  Presenters(s): Michael C. Dalsing, MD  
5:17 PM - 5:23 PM Indications, Techniques And Results With Treatment Of Venous Malformations: How Well Does Embolo/Sclerotherapy Work?
  Presenters(s): Byung-Boong Lee, MD  
5:24 PM - 5:30 PM What’s New In the Medical Treatment Of Thromboembolism: How To Combat The Role Of Inflammation
  Presenters(s): Thomas W. Wakefield, MD  
5:31 PM - 5:37 PM Is There Anything New On The Horizon With IVC Filters?
  Presenters(s): David Rosenthal, MD  
5:38 PM - 5:44 PM Debunking Some Commonly Held Beliefs About Varicose Veins: Some Shocking Myths And Misconceptions About Varicose Veins And Their Treatment
  Presenters(s): Kevin G. Burnand, MBBS, FRCS, MS  
5:45 PM - 5:51 PM What Is The Best Method For Obliterating Perforators In 2007: SEPS, Surgery, Duplex-Guided Sclerotherapy Or Duplex-Guided Radiofrequency: When Should They Be Used?
  Presenters(s): Peter Gloviczki, MD  
5:52 PM - 5:58 PM Thromboprophylaxis For Arterial And Venous Surgery: What To Use, How To Decide
  Presenters(s): Joseph A. Caprini, MD  
5:59 PM - 6:05 PM Chemical Ablation Of Varicose Veins Under Controlled Ischemia: Advantages, Techniques And Results
  Presenters(s): J. Leonel Villavicencio, MD  
6:06 PM - 6:12 PM How To Perform Sclerotherapy And Radiofrequency Effectively In An Office Practice
  Presenters(s): Alan M. Dietzek, MD, FACS, RPVI  
6:13 PM - 6:20 PM Is There Any Association Between Obesity And Chronic Venous Disease Of The Legs?
  Presenters(s): Bo G. Eklof, MD, PhD  
6:20 PM - 6:27 PM With Varicose Veins We Really Don’t Need To Obliterate The Long Saphenous Vein!
  Presenters(s): John J. Bergan, MD  
6:27 PM - 6:40 PM Panel Discussion
END OF SESSION XXVI
 
SESSION XXVII SCHEDULE
Saturday
SESSION XXVII: NEW DEVELOPMENTS IN THE TREATMENT OF ABDOMINAL AORTIC ANEURYSMS: OPEN, EVAR, LAPAROSCOPIC AND OTHER TECHNIQUES (6 AND 7-MINUTE TALKS)
x
6:40 AM - 6:47 AM Update On Robotics And Robot-Assisted Laparoscopic Vascular Surgery: Its Main Value Is Not For Operations On The Aorta But For Other Vascular Procedures
  Presenters(s): Willem Wisselink, MD  
6:48 AM - 6:55 AM Current Limitations Of Laparoscopic AAA Surgery: What Can And Cannot Be Done
  Presenters(s): Olivier A. Goëau-Brissonnière, MD, PhD  
6:56 AM - 7:03 AM Debate: The Case For Open Repair Of AAAs
  Presenters(s): Philippe Piquet, MD  
7:04 AM - 7:11 AM Debate: There Is No Case For Open Repair Of AAAs: EVAR Is Always The Preferred Treatment
  Presenters(s): James May, MD, MS, FRACS, FACS  
7:12 AM - 7:19 AM The EVAR II Trial Shows That The Intention To Treat By EVAR Confers No Benefit In High Risk AAA Patients But Fails To Show That EVAR Should Not Be Performed In Patients Deemed Unfit For Open Repair
  Presenters(s): Geoffrey L. Gilling-Smith, MS, FRCS  
7:20 AM - 7:27 AM How Does One Make A Patient Unfit For Open Repair Fit For EVAR?
  Presenters(s): Michael L. Marin, MD  
7:28 AM - 7:35 AM Update On Methods To Prevent Abdominal Compartment Syndrome With EVAR For Ruptured AAA
  Presenters(s): Dieter O. Mayer, MD / Mario Lachat, MD  
7:36 AM - 7:45 AM Panel Discussion
Moderator(s): Roger M. Greenhalgh, MD / Wesley S. Moore, MD  
7:45 AM - 7:51 AM What Percent Of Ruptured AAAs Can Be Treated Endovascularly If EVAR Is Used Preferentially And Is It Cost Effective?
  Presenters(s): Eric L.G. Verhoeven, MD, PhD  
7:52 AM - 7:58 AM EVAR Should Be The Gold Standard For Treatment Of Ruptured AAAs: All Vascular Surgeons Should Be Prepared To Do It And Do It Right
  Presenters(s): Frank J. Veith, MD  
7:59 AM - 8:05 AM EVAR Is No Better Than Open Repair For Ruptured AAAs
  Presenters(s): Jacob Buth, MD  
8:06 AM - 8:12 AM Debate: EVAR For Ruptured AAAs May Be Attractive But It Should Be Restricted To Stable Patients And We Need A Randomized Trial To Prove Superiority
  Presenters(s): Marc R.H. van Sambeek, MD, PhD  
8:13 AM - 8:19 AM Debate: EVAR Is Feasible In Stable And Unstable Patients With Ruptured AAAs And Reduces Mortality: We Don’t Need A Randomized Study
  Presenters(s): Manish Mehta, MD, MPH  
8:20 AM - 8:26 AM EVAR Is A Proven Treatment For Ruptured AAAs And Is Most Effective In Unstable Patients
  Presenters(s): Randy D. Moore, MD  
8:27 AM - 8:33 AM Consequences Of Early And Late Open Conversion Following EVAR: How To Make It Less Morbid
  Presenters(s): Wesley S. Moore, MD  
8:34 AM - 8:40 AM Five-Year Follow-up Of EVAR Patients Increases The Global Cost 50%
  Presenters(s): W. Charles Sternbergh III, MD  
8:40 AM - 8:48 AM Panel Discussion
END OF SESSION XXVII
 
SESSION XXVIII SCHEDULE
Saturday
SESSION XXVIII: PROGRESS IN THE TREATMENT OF DISEASES OF THE AORTA AND ITS BRANCHES (6-MINUTE TALKS)
x
8:48 AM - 8:54 AM Are There Limits To The Endovascular Treatment Of Aortoiliac Occlusive Disease: What Are They?
  Presenters(s): Peter G. Kalman, MD  
8:55 AM - 9:01 AM Debate: Celiac And SMA Stenting Has A High Recurrence Rate And Should Only Be Used When Open Repair Is Not An Option
  Presenters(s): Richard P. Cambria, MD  
9:02 AM - 9:08 AM Debate: Celiac And SMA Stenting Should Be Used In All Patients Requiring Revascularization: If Done Right, Recurrence Is Not A Problem
  Presenters(s): Krassi Ivancev, MD, PhD  
9:09 AM - 9:15 AM Tips And Tricks To Deal Surgically With A Heavily And Circumferentially Calcified Aorta
  Presenters(s): Michel A. Bartoli, MD / Alain Branchereau, MD  
9:16 AM - 9:22 AM Iliac Artery Aneurysm Repair: Comparison Of Endo And Open Techniques
  Presenters(s): James F. McKinsey, MD  
9:23 AM - 9:29 AM Iliac Artery Aneurysms: Strategies For Endovascular Treatment And Selection Of Grafts
  Presenters(s): Jacques Busquet, MD  
9:30 AM - 9:36 AM Deep Vein Grafts To Improve Results In Young Patients With Aortoiliac Disease And Small Arteries: Are They Better Than PTA And Stents?
  Presenters(s): G. Patrick Clagett, MD  
9:37 AM - 9:43 AM Renal Artery Aneurysms: Do They Grow And How Are They Best Managed In The Endovascular Era?
  Presenters(s): Neal S. Cayne, MD  
9:44 AM - 9:50 AM What’s New With The Treatment Of Renal Artery Stenosis: Should We Be More Or Less Aggressive And How Frequent Is Significant In-Stent Stenosis?
  Presenters(s): Thomas A. Sos, MD  
9:51 AM - 10:00 AM Panel Discussion
END OF SESSION XXVIII
 
SESSION XXIX SCHEDULE
Saturday
SESSION XXIX: ISSUES OF IMPORTANCE TO VASCULAR SURGERY
x
10:00 AM - 10:06 AM Innovation In Vascular Surgery Education For Medical Students And Residents
  Presenters(s): Thomas S. Riles, MD  
10:07 AM - 10:13 AM Current Vascular Trainees (Fellows) Are Not Receiving Sufficient Training In Open Vascular Cases: High Volume Private Practices Must Participate In Vascular Surgical Training
  Presenters(s): John F. Eidt, MD  
10:14 AM - 10:23 AM Should Vascular Surgery Be An Independent Specialty: A View From Abroad And Why It Is Not Happening In Some Countries Including The United States
  Presenters(s): Peter R.F. Bell, MD, FRCS, DSC, KBE  
10:24 AM - 10:29 AM Panel Discussion
END OF SESSION XXIX
 
SESSION XXX SCHEDULE
Saturday
SESSION XXX: HONOR THE MILITARY, VASCULAR SURGEONS AND THEIR ACCOMPLISHMENTS (7-MINUTE TALKS)
x
10:29 AM - 10:36 AM The Vietnam Vascular Registry With Over 10,000 Vascular Injuries To Soldiers: What Lessons Can It Teach Us Today?
  Presenters(s): Norman M. Rich, MD, FACS, DMCC  
10:37 AM - 10:44 AM Vascular Surgery In Iraq: Damage Control Resuscitation And Other Advances In Modern War Time Vascular Surgery
  Presenters(s): Charles J. Fox, MD, FACS / David L. Gillespie, MD  
10:45 AM - 10:52 AM Military Medical Care In Austere Special Ops Environments: What Can Be Accomplished?
  Presenters(s): Stephen F. McCartney, MD, FACS  
10:53 AM - 10:56 AM Panel Discussion
END OF SESSION XXX
 
SESSION XXXI SCHEDULE
Saturday
SESSION XXXI: RAPID FIRE UPDATE ON ECONOMIC AND BUSINESS ISSUES FOR VASCULAR SURGEONS (5-MINUTE TALKS)
x
10:56 AM - 11:01 AM What Vascular Surgeons Need To Know About “Outcome Measures” And How They Will Affect Their Practice And Their Bottom Line
  Presenters(s): Anton N. Sidawy, MD, MPH  
11:02 AM - 11:07 AM How To Structure A Vascular Practice To Survive Financially With Present Reimbursement Policies In The US
  Presenters(s): Robert M. Zwolak, MD, PhD  
11:08 AM - 11:13 AM How To Optimize The Value Of A Venous Practice
  Presenters(s): Clifford M. Sales, MD, MBA  
11:14 AM - 11:19 AM How To Bill And Code To Maximize Revenue In Vascular Surgery: 10 Top Tips
  Presenters(s): Sean P. Roddy, MD  
11:20 AM - 11:25 AM Impact Of Changing Treatment For Infrainguinal Disease On Professional Reimbursement
  Presenters(s): Thomas F. O'Donnell, Jr., MD  
11:26 AM - 11:31 AM Vascular Surgeon Owned Outpatient Endovascular Centers: A Way To Bring Enlightened Vascular Surgery To Underserved Areas
  Presenters(s): Sam S. Ahn, MD, FACS, MBA  
11:32 AM - 11:37 AM How Vascular Screening Can Enhance The Practice Of Vascular Surgery
  Presenters(s): William R. Flinn, MD  
11:38 AM - 11:43 AM Update On Malpractice Relief: Is There Any Hope?
  Presenters(s): O. William Brown, MD, JD  
11:44 AM - 11:49 AM Comparison Of Economic Impact Of Endovascular And Open Procedures In Various Vascular Beds: Is Endo Profitable Or A Loser?
  Presenters(s): Richard M. Green, MD  
11:50 AM - 11:58 AM Panel Discussion
END OF SESSION XXXI
 
SESSION XXXII SCHEDULE
Saturday
SESSION XXXII: LUNCHEON SESSION ON NEW TECHNOLOGIES FOR EVAR (6-MINUTE TALKS WITH LUNCH PROVIDED)
x
11:58 AM - 12:04 PM With Certain Anatomic Features The New Flexible Aorfix Graft Should Be The Endograft Of Choice: Reasons Why And Clinical Experience
  Presenters(s): Brian R. Hopkinson, ChM, FRCS  
12:05 PM - 12:11 PM Clinical Results With The New VI Datascope Endograft For Ruptured AAAs And Other Unfavorable Anatomy
  Presenters(s): Ralf R. Kolvenbach, MD / László Pintér, MD  
12:12 PM - 12:18 PM Why The Endologix Powerlink Endograft With Fixation On The Aortic Bifurcation Is Best For Most AAAs: Why Is It Good For Flared Necks And When Can It Not Be Used?
  Presenters(s): Dieter Raithel, MD, PhD  
12:16 PM - 12:32 PM The Anaconda Endograft For AAAs: A Redeployable Graft With Magnetic Assisted Limb Deployment
  Presenters(s): Donald B. Reid, MD  
12:19 PM - 12:25 PM Technical Options For The Ectatic, Aneurysmal Or Short Common Iliac Artery With EVAR
  Presenters(s): Michael Lawrence-Brown, MB,BS, FRACS  
12:33 PM - 12:39 PM The Aptus Endovascular AAA Repair System: Advantages And Clinical Experience To Date
  Presenters(s): David H. Deaton, MD  
12:40 PM - 12:46 PM Endurant Endograft For EVAR: Advantages Of The Next Generation Medtronic Device
  Presenters(s): Hence J.M. Verhagen, MD, PhD  
12:47 PM - 12:53 PM Aortouni-iliac Unifit Endograft (LeMaitre Vascular): Phase I Clinical Trial Update
  Presenters(s): Rodney A. White, MD  
12:54 PM - 1:00 PM Panel Discussion
END OF SESSION XXXII
 
SESSION XXXIII SCHEDULE
Saturday
SESSION XXXIII: ETHICAL ISSUES AND WHAT THE FUTURE WILL LOOK LIKE (7-MINUTE TALKS)
x
1:00 PM - 1:07 PM What Impact Will Nano Technology And Nano Particles Have On The Vascular Surgery Of The Future?
  Presenters(s): Elliot L. Chaikof, MD, PhD  
1:08 PM - 1:15 PM What Is The FDA Going To Do About Off-Label Use Of Biliary Stents In Blood Vessels?
  Presenters(s): Dorothy B. Abel, BSBME  
1:16 PM - 1:23 PM The Importance Of National Awareness Programs To Vascular Surgeons
  Presenters(s): Alan T. Hirsch, MD  
1:24 PM - 1:31 PM How Have Randomized Controlled Trials Wrecked The Reimbursement System For Carotid Stenting In Belgium?
  Presenters(s): Patrick Peeters, MD  
1:32 PM - 1:37 PM Panel Discussion
END OF SESSION XXXIII
 
SESSION XXXIV SCHEDULE
Saturday
SESSION XXXIV: PREVENTION AND TREATMENT OF COMPLICATIONS (5-MINUTE RAPID FIRE PRESENTATIONS)
x
1:37 PM - 1:42 PM Technique To Salvage A TAG Thoracic Endograft That Fails To Deploy
  Presenters(s): W. Anthony Lee, MD  
1:43 PM - 1:48 PM Is MRI Of The Abdomen Or Elsewhere Safe After Placement Of A Stainless Steel Aortic Endograft Like The Zenith?
  Presenters(s): Timothy A.M. Chuter, DM  
1:49 PM - 1:54 PM What The Vascular Interventionist Or Surgeon Needs To Know About Discontinuing Plavix In A Patient With A Drug Eluting Coronary Stent
  Presenters(s): Ali Amin, MD, RVT, FACS, FACC  
1:55 PM - 2:00 PM Improved Treatment Of Trash Foot (Microembolization) After Endo And Open AAA Repair: Bypasses And Thrombectomy Of Foot Arteries Can Save The Foot
  Presenters(s): Nicholas J. Gargiulo III, MD / Frank J. Veith, MD  
2:01 PM - 2:06 PM When A Central Venous Catheter Is Mistakenly Placed In An Artery The Problem Can Be Solved With A Percutaneous Closure Device
  Presenters(s): Claudio J. Schönholz, MD  
2:07 PM - 2:12 PM Type II Endoleaks After EVAR Is A Bad Prognostic Sign And Can Lead To Rupture
  Presenters(s): David C. Brewster, MD  
2:13 PM - 2:18 PM Thrombolysis: An Occasional Effective Treatment For Acute Blindness
  Presenters(s): Jos C. van den Berg, MD, PhD  
2:19 PM - 2:24 PM Arterial Reconstructions In Infected Fields Can Be Effective In High Risk Patients
  Presenters(s): Peter Gloviczki, MD  
2:25 PM - 2:30 PM Is Paraplegia Ever A Consideration After EVAR: Should Patients Be Informed?
  Presenters(s): Patrice F. Bergeron, MD  
2:31 PM - 2:36 PM Aortic Endografts In Marfan’s Patients: Helpful Or Senseless?
  Presenters(s): Dietmar H. Koschyk, MD  
2:37 PM - 2:42 PM The Evidence For The Need For Embolic Protection Devices During Renal Artery Stenting
  Presenters(s): Matthew S. Edwards, MD  
2:43 PM - 2:56 PM Panel Discussion
END OF SESSION XXXIV
 
SESSION XXXV SCHEDULE
Saturday
SESSION XXXV: UPDATES AND NEW TECHNIQUES (6-MINUTE TALKS)
x
2:56 PM - 3:02 PM Will A Paclotaxil Vascular Wrap Decrease Anastomotic Neointimal Hyperplasia: Experimental Evaluation And Initial Clinical Results With A-V Fistulas And Leg Bypasses
  Presenters(s): Ted R. Kohler, MD  
3:03 PM - 3:09 PM Update On The UK Small AAA Trial: Do The 12-Year Results Change Any Conclusion?
  Presenters(s): Janet T. Powell, MD, PhD  
3:10 PM - 3:16 PM Intraluminal Thrombus In AAAs: Is It Good Or Bad With Regard To Rupture Risk?
  Presenters(s): David A. Vorp, PhD  
3:17 PM - 3:23 PM Is AAA Rupture Risk Related To Whether Patients Are Candidates For EVAR Or Require Open Repair: Why Does It Matter?
  Presenters(s): Mark F. Fillinger, MD  
3:24 PM - 3:30 PM Significance Of Bleeding Into AAA Sac Thrombus: What Is The “Crescent Sign” And Does It Or Other Subtle CT Signs Predict Rupture?
  Presenters(s): Jesper Swedenborg, MD, PhD  
3:31 PM - 3:37 PM 3D Imaging Is A Better Way To Follow Patients For Endograft Migration
  Presenters(s): Sean P. Lyden, MD  
3:38 PM - 3:44 PM 3D Imaging For Rapid (10-Minute) Planning For Fenestrated And Branched Endografts
  Presenters(s): Timothy A. Resch, MD, PhD  
3:45 PM - 3:53 PM Panel Discussion
Moderator(s): Anthony J. Comerota, MD, FACS, FACC / Hugh G. Beebe, MD  
3:53 PM - 3:59 PM Open Surgical Endarterectomy Is Still The Preferred Treatment For Common Femoral Artery Disease
  Presenters(s): Glenn M. LaMuraglia, MD  
4:00 PM - 4:06 PM Routine Kidney Perfusion Cooling For All Open Renal Artery Procedures Is A Better Way: Rationale, Technique And Results
  Presenters(s): Willem Wisselink, MD  
4:07 PM - 4:13 PM Not All Type I Endoleaks After EVAR Have To Be Fixed: When Is It OK To Observe Them?
  Presenters(s): W. Anthony Lee, MD  
4:14 PM - 4:20 PM Tips And Tricks To Facilitate Percutaneous EVAR And TEVAR: When Is It Contraindicated?
  Presenters(s): Marc R.H. van Sambeek, MD, PhD  
4:21 PM - 4:27 PM Retrograde Stenting of the SMA via Laparotomy: A Useful Bailout in Acute Bowel Ischemia
  Presenters(s): Bjõrn Sonesson, MD, PhD / Krassi Ivancev, MD, PhD  
4:28 PM - 4:34 PM Portal Vein Reconstruction During Whipple Procedures: Technique And Optimal Conduit
  Presenters(s): Gregory L. Moneta, MD  
4:35 PM - 4:41 PM Brain Injury Markers After CEA And CAS: Are There Differences And What Is The Role Of The Circle Of Willis In Predicting Which Patients Should Get Which Treatment?
  Presenters(s): Nicholas J.W. Cheshire, MD  
4:42 PM - 4:50 PM Panel Discussion
Moderator(s): Gregorio A. Sicard, MD / K. Wayne Johnston, MD, FRCS  
4:51 PM - 4:57 PM European Silvergraft Registry: Can The Silvergraft Prevent Graft Infections In Patients At Risk?
  Presenters(s): Max Zegelman, MD, PhD  
4:58 PM - 5:04 PM Stem Cell Therapy For Peripheral Vascular Disease: Hype Or Hope?
  Presenters(s): Michael P. Murphy, MD  
5:05 PM - 5:11 PM Which Is More Useful In Evaluating Critical Limb Ischemia Noninvasively: Transcutaneous Oxygen Or Toe Pressures?
  Presenters(s): Torben V. Schroeder, MD, DMSc  
5:12 PM - 5:18 PM Improvement In PTA With The Use Of The AngioSculpt Scoring Balloon For Infrapopliteal Lesions In Patients With Critical Limb Ischemia
  Presenters(s): Patrick Peeters, MD  
5:19 PM - 5:25 PM Revascularization To Achieve Wound Healing: Are Endovascular Techniques As Effective As Bypasses
  Presenters(s): Richard F. Neville, MD  
5:26 PM - 5:32 PM CAS For Radiation Induced Stenosis Yields Suboptimal Results
  Presenters(s): Zvonimir Krajcer, MD, FACC  
5:33 PM - 5:39 PM Expanding The Indications For EVAR With Hybrid Device Approaches
  Presenters(s): Jeffrey P. Carpenter, MD  
5:40 PM - 5:46 PM The Best Of Charing Cross 2007
  Presenters(s): Roger M. Greenhalgh, MD  
5:47 PM - 5:53 PM The Globalstar Thoracic Endograft Registry: Design And Future Potential
  Presenters(s): S. Rao Vallabhaneni, MD, FRCS  
5:54 PM - 6:00 PM Update On The U.S. Trial Of The Aorfix Endograft For The Treatment Of Difficult AAAs
  Presenters(s): Mark F. Fillinger, MD  
6:01 PM - 6:07 PM 12-Month Results Of The Pivotal Trial For The Abdominal Stent Graft
  Presenters(s): Michael L. Marin, MD  
6:07 PM - 6:15 PM Panel Discussion
END OF SESSION XXXV
 
SESSION XXXVI SCHEDULE
Sunday
SESSION XXXVI: NEW DEVELOPMENTS, TECHNICAL ADVANCES AND UPDATES (6 AND 7-MINUTE TALKS)
x
6:45 AM - 6:51 AM Debate: Eversion Carotid Endarterectomy Is Better And More Durable Than Standard CEA
  Presenters(s): Dhiraj M. Shah, MD  
6:52 AM - 6:58 AM Debate: Standard CEA And Eversion CEA Yield Comparable Results: Do What You Do Best
  Presenters(s): Richard P. Cambria, MD  
6:59 AM - 7:05 AM Drug Coated Balloons Can Prevent Restenosis After Infrainguinal PTA
  Presenters(s): Gunnar Tepe, MD  
7:06 AM - 7:12 AM Advantages And Limitations Of The Implantable CardioMems Pressure Sensor In The Management Of Patients After EVAR
  Presenters(s): Richard L. McCann, MD  
7:13 AM - 7:19 AM Should Use Of Long-Term Intrasac Pressure Measurements Be Used Routinely After EVAR For AAAs: What Are The Limitations?
  Presenters(s): Jan S. Brunkwall, MD, PhD  
7:20 AM - 7:27 AM Stent-Grafting Of The Entire Aortic Arch Using Cerebral Circulatory Support And Retrograde In Situ Fenestration: Technique And Experimental Evaluatio
  Presenters(s): Furuzan Numan, MD  
7:28 AM - 7:36 AM Panel Discussion
Moderator(s): Giorgio M. Biasi, MD / Larry H. Hollier, MD  
7:36 AM - 7:43 AM How To Treat Abdominal Aortic Coarctation: Bypass, Patch, Replacement Or Stent?
  Presenters(s): James C. Stanley, MD  
7:44 AM - 7:51 AM Newer Catheter Deliverable Embolic Agents And Glues: Indications, Techniques And Precautions
  Presenters(s): Timur P. Sarac, MD  
7:52 AM - 7:59 AM What Will ACST Tell Us That Is Applicable Today: Do We Need A Best Medical Management Arm In Any Carotid Treatment Trial Of Asymptomatic Patients?
  Presenters(s): Alison Halliday, MS, FRCS  
8:00 AM - 8:07 AM The Role For Tibial Angioplasty And Stenting: Technical Tips
  Presenters(s): Peter A. Schneider, MD  
8:08 AM - 8:15 AM Importance Of Inflammation In Carotid Artery Disease: What The Vascular Surgeon Needs To Know
  Presenters(s): Christos D. Liapis, MD  
8:16 AM - 8:23 AM Iliac Branch Device: The Early Australian Experience
  Presenters(s): Brendan M. Stanley, MD  
8:24 AM - 8:32 AM Panel Discussion
END OF SESSION XXXVI
 
SESSION XXXVII SCHEDULE
Sunday
SESSION XXXVII: MORE ON THORACIC AND ABDOMINAL ANEURYSMS (6-MINUTE RAPID FIRE TALKS)
x
8:32 AM - 8:38 AM Debate: EVAR Is Best For Fitter Patients And Not Good For Patients Unfit For Open Surgery
  Presenters(s): Jan D. Blankensteijn, MD  
8:39 AM - 8:45 AM Debate: EVAR II Is Not Valid: Patients Unfit For Open Repair Are Still Good Candidates For EVAR
  Presenters(s): Peter L. Harris, MD, FRCS  
8:46 AM - 8:52 AM Complications Of Arch And Visceral Debranching: They Are Not So Easy And Have Morbidity And Mortality
  Presenters(s): Frank J. Criado, MD, FACS, FSVM  
8:53 AM - 8:59 AM How To Follow Patients With The Older, More Permeable Version Of The Excluder Graft: What To Do If The AAA Enlarges A Lot?
  Presenters(s): Jon S. Matsumura, MD  
9:00 AM - 9:06 AM Posture Dependent Intermittent Endoleaks: A Cause Of Endotension After EVAR: How To Detect And Treat?
  Presenters(s): James May, MD, MS, FRACS, FACS  
9:07 AM - 9:13 AM Pitfalls In Sizing Of Stent-Grafts For Traumatic Aortic Rupture: Does Aortic Diameter Change With Hypotension: Do Customized Grafts Help And How Can They Be Obtained?
  Presenters(s): Burkhart Zipfel, MD  
9:14 AM - 9:21 AM Panel Discussion
Moderator(s): John E. Connolly, MD / Thomas F. Panetta, MD  
9:21 AM - 9:27 AM Technical Steps For Increasing The Seal Zone When Using The Gore Excluder Graft In AAAs With Short Necks: The Endowedge And Kilt Methods
  Presenters(s): David J. Minion, MD  
9:28 AM - 9:34 AM EVAR In High Risk Patients With Anatomy Unsuitable For Most Commercially Available Endografts: How Can It Be Done Effectively?
  Presenters(s): Christopher K. Zarins, MD  
9:35 AM - 9:41 AM Advantages Of A Multilayer Stent In The Treatment Of Aneurysmal And Occlusive Disease
  Presenters(s): Armando C. Lobato, MD, PhD  
9:42 AM - 9:48 AM Limb Occlusion Following EVAR With Bifurcated Grafts: How To Prevent And How Best To Treat?
  Presenters(s): Jean-Pierre Becquemin, MD, FRCS  
9:49 AM - 9:55 AM Prophylactic Renal Artery Stenting Prior To EVAR: When To Do It And How To Do It Safely
  Presenters(s): Joshua L. Weintraub, MD, FSIR  
9:56 AM - 10:02 AM Tips And Tricks To Facilitate Use Of The Gore TAG Device For TEVARs
  Presenters(s): Jan S. Brunkwall, MD, PhD  
10:03 AM - 10:10 AM Panel Discussion
END OF SESSION XXXVII
 
SESSION XXXVIII SCHEDULE
Sunday
SESSION XXXVIII: NEW DEVELOPMENTS IN DISEASES OF THE CAROTID, VERTEBRALS AND SUPRA-AORTIC TRUNKS (7-MINUTE TALKS)
x
10:10 AM - 10:17 AM Value Of Cerebral Oximetry In Patients Undergoing CEA And CAS
  Presenters(s): Ross Milner, MD  
10:18 AM - 10:25 AM Debate: CAS For Acute Stroke: When, When Not And How?
  Presenters(s): L. Nelson Hopkins, MD  
10:26 AM - 10:33 AM Debate: Surgery (CEA) For Acute Stroke: When, When Not And How?
  Presenters(s): Wilhelm Sandmann, MD  
10:34 AM - 10:41 AM How Can CAS Be Performed With Safety And Durability In High Risk Symptomatic Patients As Part Of A Vascular Practice?
  Presenters(s): Ali F. AbuRahma, MD  
10:42 AM - 10:49 AM What Is The Learning Curve With CAS And How Can We Short Circuit It?
  Presenters(s): Piergiorgio Cao, MD, FRCS  
10:50 AM - 10:57 AM Ten Top Tips For Safe Effective CAS: A Vascular Surgeon’s View
  Presenters(s): Michael B. Silva, Jr., MD  
10:58 AM - 11:05 AM Ten Top Tips For Safe Effective CAS: An Interventional Cardiologist’s View
  Presenters(s): Sriram S. Iyer, MD  
11:06 AM - 11:13 AM Status Of CREST And Other Randomized Trials: When Will They Provide Answers?
  Presenters(s):   
11:14 AM - 11:23 AM Panel Discussion
END OF SESSION XXXVIII
 
SESSION XXXIX SCHEDULE
Sunday
SESSION XXXIX: NEW DEVELOPMENTS IN CAROTID STENTING (6-MINUTE TALKS)
Moderators:  / Michael B. Silva, Jr., MD
x
11:23 AM - 11:29 AM Should We Worry About Post-Approval CAS In The Community: Is The CAPTURE Trial Really Supportive Of Widespread Adoption Of CAS As Some Have Suggested?
  Presenters(s): Ruth L. Bush, MD, MPH  
11:30 AM - 11:36 AM Widespread Carotid Stenting (CAS) Has A Higher Procedural Mortality Than CEA Based On A US Nationwide Database: This Difference Was Even More Pronounced In Patients With A Preop Stroke
  Presenters(s): John Blebea, MD  
11:37 AM - 11:43 AM How To Manage Patients With Tandem Lesions At The Carotid Bifurcation And Origin
  Presenters(s): Peter H. Lin, MD  
11:44 AM - 11:50 AM Advantages And Disadvantages Of Various Embolic Protection Devices
  Presenters(s): Daniel G. Clair, MD  
11:51 AM - 11:57 AM Simplified Technique For CAS Via A Cervical Mini-Incision With Flow Reversal Cerebral Protection: Technique And Results
  Presenters(s): David W. Chang, MD  
11:58 AM - 12:04 PM New Techniques For Neurorescue And When Are They Indicated?
  Presenters(s): Frank J. Criado, MD, FACS, FSVM  
12:05 PM - 12:11 PM Is CAS More Risky In Patients Over 80: How Can This Risk Be Minimized?
  Presenters(s): Klaus D. Mathias, MD  
12:12 PM - 12:18 PM Carotid Artery Disease: Forget Stenosis, It’s All About Neovascularization, Plaque Composition And Vulnerability
  Presenters(s): William P. Paaske, MD, DrMedSci, FRCS, FRCS Ed, FACS  
12:19 PM - 12:25 PM How To Provide Reversal Of Flow Embolic Protection For Vertebral Artery Angioplasty And Stenting
  Presenters(s): Claudio J. Schönholz, MD  
12:26 PM - 12:32 PM Indications, Techniques And Precautions For The Brachial Approach For CAS: Other Tips For Dealing With Difficult Arches
  Presenters(s): Peter A. Schneider, MD  
12:33 PM - 12:45 PM Panel Discussion
END OF SESSION XXXIX
 
SESSION XL SCHEDULE
Sunday
SESSION XL: NEW CONCEPTS, ADVANCES AND LATE BREAKING TRIALS (5-MINUTE FAST PACED TALKS)
x
12:45 PM - 12:50 PM Endovascular Treatment For COPD: A New Horizon
  Presenters(s): David H. Deaton, MD  
12:51 PM - 12:56 PM Experience With Stent-Graft Repair Of Carotid Artery Aneurysms
  Presenters(s): Klaus D. Mathias, MD  
12:57 PM - 1:02 PM Tips And Tricks To Facilitate Endovascular Repair Of Ruptured AAAs, Including Fascial Closure Of Femoral Puncture Sites
  Presenters(s): Thomas Larzon, MD  
1:03 PM - 1:08 PM Is There A Role For Interventional Treatment Of Portal Bed Thrombosis?
  Presenters(s): Matthew A. Mauro, MD  
1:09 PM - 1:14 PM Update On Indications, Techniques, Devices And Complications Of Endovascular Large Artery Occluders (Plugs)
  Presenters(s): Enrique Criado, MD, FACS  
1:15 PM - 1:20 PM Intravascular MRI: Is It The Magic Bullet For Detecting A Vulnerable Plaque In The Heart Or In The Carotid Artery?
  Presenters(s): Ron Waksman, MD  
1:21 PM - 1:26 PM Debate: Timing Of CEA After A Small Stroke: It Is Best To Delay Surgery For 4 Weeks
  Presenters(s): Caron B. Rockman, MD  
1:27 PM - 1:32 PM Debate: Should A Stroke Be Considered As A Medical Emergency For Treatment By CEA: Delay Is Good For The Surgeon’s Results But Not For The Patient
  Presenters(s): A. Ross Naylor, MD, FRCS  
1:33 PM - 1:38 PM The Role And Effectiveness Of Renal Artery Stenting And Open Reconstruction: Is There Still A Place For Open Surgery?
  Presenters(s): Christopher J. Kwolek, MD  
1:39 PM - 1:44 PM Handheld Ultrasound Volume Indicator For AAA Sac Volume Determination: A Better Way For Post-Procedural Surveillance
  Presenters(s): Marc R.H. van Sambeek, MD, PhD  
1:45 PM - 1:50 PM Advantages And Limitations Of Flow Reversal Embolic Protection During CAS
  Presenters(s): Juan C. Parodi, MD  
1:51 PM - 1:56 PM Impact Of Iron Storage, Blood Letting And Cytokines On Atherosclerosis: How Can Vascular Surgeons Use This Information?
  Presenters(s): Ralph G. DePalma, MD  
1:57 PM - 2:02 PM The SPACE And EVA 3S Trials: What Effect Are They Having On Carotid Treatment In Europe?
  Presenters(s): Nicholas J.W. Cheshire, MD / Eric L.G. Verhoeven, MD, PhD / Piergiorgio Cao, MD, FRCS  
2:03 PM - 2:08 PM Internal Iliac Revascularization For Limb Salvage
  Presenters(s): Dipankar Mukherjee, MD  
2:09 PM - 2:14 PM SFA Percutaneous Intervention To Optimize Flow For Distal Bypass Grafts: An Effective And Durable Combination For Critical Ischemia
  Presenters(s): Michael Belkin, MD / Michael S. Conte, MD  
2:15 PM - 2:25 PM Panel Discussion
2:25 PM - 2:30 PM Prize Drawing Raffle – You Must Be Present To Win
2:30 PM - 2:30 PM Symposium Ends
END OF SESSION XL